SCHEMBL4782596

SCHEMBL4782596

CS(=O)(=O)n1ccnc1C(CC(=O)O)c1ccc(OCc2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 19/20 0.54
MAPT P10636 1/20 0.47
FFAR4 Q5NUL3 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4782592 1.00 FFAR1 (0.54) FFAR1MAPTFFAR4
SCHEMBL4736863 0.86 FFAR1 (0.68) FFAR1MAPT
SCHEMBL4736855 0.86 FFAR1 (0.68) FFAR1MAPT
SCHEMBL4804081 0.78 FFAR1 (0.75) FFAR1MAPT
SCHEMBL4804068 0.78 FFAR1 (0.75) FFAR1MAPT
SCHEMBL4739724 0.78 FFAR1 (0.61) FFAR1FFAR4
SCHEMBL4737595 0.78 FFAR1 (0.60) FFAR1FFAR4
SCHEMBL4739732 0.78 FFAR1 (0.61) FFAR1FFAR4
SCHEMBL4740999 0.78 FFAR1 (0.60) FFAR1FFAR4
SCHEMBL4786197 0.75 FFAR1 (0.55) FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893582-A2 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE IN TREATING METABOLIC DISORDERS Amgen, Inc (US) 2008-03-05 EP disclosed
WO-2006127503-A2 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE IN TREATING METABOLIC DISORDERS AMGEN INC (US) 2006-11-30 WO disclosed